• Press
  • Offices
  • Contact
  • Legal notice
  • EN
    • DE
  • UPC
  • Firm
    • Main Focus
    • History
    • Guiding Principle
    • Awards and Rankings
  • Our Practice
    • Legal Areas
    • Industries
  • Our Team
  • Career
    • Working with us
  • News & Knowledge
    • News
    • Events
    • UPC-Update
    • IP-Update
    • Brexit-Update
    • Publications
    • B&B Bulletin
  • Menu Menu
FIND EXPERTS
  • UPC
  • Firm
    • Main Focus
    • History
    • Guiding Principle
    • Awards and Rankings
  • News & Knowledge
    • News
    • Events
    • UPC-Update
    • IP-Update
    • Brexit-Update
    • Publications
    • B&B Bulletin
  • FIND EXPERTS
  • Contact
  • Our Practice
    • Legal Areas
    • Industries
  • Our Team
  • Career
    • Working with us
  • Offices
  • EN
    • DE

Dr. Jan B. Krauß as co-author of scientific article on therapy of skin disease Epidermolysis bullosa junctionalis

8. September 2021/in Publications, Patents and Utility Models

In the context of his work at the University of Salzburg, BOEHMERT & BOEHMERT patent attorney Dr. Jan B. Krauß has published an article as co-author on the topic “Drug Development for Target Ribosomal Protein rpL35/uL29 for Repair of LAMB3R635X in Rare Skin Disease Epidermolysis Bullosa”.

In the scientific paper, atazanavir and artesunate are identified as candidate compounds that bind to the ribosomal protein rpL35. The compounds are currently being tested for their potential to trigger a rpL35 ribosomal switch to increase the production of full-length Lamb3 protein from a LAMB3PTC mRNA. This serves as a targeted systemic therapy in treating the rare genetic blistering skin disorder severe junctional epidermolysis bullosa.

Dr. Krauß published the article together with A. Rathner, P. Rathner, A. Friedrich, M. Wießner, CM. Kitzler, J. Schernthaner, T. Karl, F. Lottspeich, W. Mewes, H. Hintner, JW. Bauer, M. Breitenbach, N. Müller, H. Breitenbach-Koller and J. von Hagen.
It may be read in the July 2021 issue, Vol. 34, No. 4, of the scientific journal “Skin Pharmacology and Physiology” published by S. Karger AG and can be purchased here.

/wp-content/uploads/2022/04/boehmert_logo.svg 0 0 Petra Hettenkofer /wp-content/uploads/2022/04/boehmert_logo.svg Petra Hettenkofer2021-09-08 15:32:062022-07-25 08:37:57Dr. Jan B. Krauß as co-author of scientific article on therapy of skin disease Epidermolysis bullosa junctionalis

Author

Dr. Jan B. Krauß

Contents

More articles

  • New Commentary "Ingerl/Rohnke/­Nordemann - Markengesetz:… 2. February 2023
  • Publication of the Sedona Guidelines with co-author Dr.… 30. January 2023
  • Dr. Rudolf Böckenholt comments in GRUR-Prax judgment on the… 26. January 2023

Menu

  • Firm
  • Our Practice
  • Career
  • News & Knowledge
  • FIND EXPERTS

Informations

  • Press
  • Contact
  • Legal notice
  • Data Protection
  • General Terms and Conditions
  • Contact

Legal Areas

  • Employee Inventions
  • Data Protection
  • Designs
  • Domains
  • Information Technology
  • Anti-Trust
  • Licencing
  • Trade Marks
  • Patent Valuation
  • Patents & Utility Models
  • Patent Litigation
  • Product Piracy
  • Copyright
  • Unfair Competition

© Copyright 2023– BOEHMERT & BOEHMERT

Scroll to top

We only use functional cookies and no third party services. Learn more in our privacy policy.

Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.